{"url":"https://lda.senate.gov/api/v1/filings/676f70d6-10b2-4ffe-ade7-e32fbc481e4b/","filing_uuid":"676f70d6-10b2-4ffe-ade7-e32fbc481e4b","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2020,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/676f70d6-10b2-4ffe-ade7-e32fbc481e4b/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jonathan A. Friedman","dt_posted":"2020-04-15T12:44:14.927000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1299 Pennsylvania Avenue, NW","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":4117,"url":"https://lda.senate.gov/api/v1/registrants/4117/","house_registrant_id":30920,"name":"APCO WORLDWIDE LLC","description":"Public relations and strategic communications","address_1":"1299 Pennsylvania Avenue, NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JONATHAN A. FRIEDMAN","contact_telephone":"+1 202-778-1000","dt_updated":"2026-07-02T16:54:18.022170-04:00"},"client":{"id":103975,"url":"https://lda.senate.gov/api/v1/clients/103975/","client_id":1005558,"name":"BRAEBURN INC.","general_description":"Pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-05-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocacy regarding rules for market entry and prescription delivery.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":38118,"prefix":null,"prefix_display":null,"first_name":"BILL","nickname":null,"middle_name":null,"last_name":"PIERCE","suffix":null,"suffix_display":null},"covered_position":"Deputy Assistant Secretary for Public Affairs, Media, DHHS","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}